In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a ...

Barclays analyst Balaji Prasad maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report) today and set a price target of $28.00.

Teva Pharmaceutical Industries Ltd. and Samsung Bioepis Co., Ltd. announced that they entered into a licensing ...

An upstart biopharma firm founded by two former executives at CinCor Pharma – which celebrated a $1.8B exit to AstraZeneca in ...

The early stage company is developing a new approach to gene editing to treat rare genetic diseases. It does this using mRNA, ...

The drugs listed are in alphabetical order. Bendamustine hydrochloride injection: Apotex on Jan. 27 reported the discontinuation of both the 25 mg and 100 mg presentations of bendamustine ...

As Deckers prepares to unveil its Q3 earnings, can its innovative strategies and brand strength offset the looming margin ...

Few flavors are as comforting as chocolate. If you feel the winter blues creeping up on you, book a class with Kiki's Cocoa's ...

The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

Seattle is often overlooked for a local getaway precisely because it's our state's most famous city. Still, we think the ...

The general public can return any Hoka product within 30 days of purchase. Hoka rewards members (it’s free to sign up) get a ...

RFG Advisory LLC increased its position in Deckers Outdoor Co. (NYSE:DECK – Free Report) by 21.1% in the fourth quarter, ...